Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2017 1
2019 1
2020 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Use of colistin in adult patients: A cross-sectional study.
Giacobbe DR, Saffioti C, Losito AR, Rinaldi M, Aurilio C, Bolla C, Boni S, Borgia G, Carannante N, Cassola G, Ceccarelli G, Corcione S, Dalla Gasperina D, De Rosa FG, Dentone C, Di Bella S, Di Lauria N, Feasi M, Fiore M, Fossati S, Franceschini E, Gori A, Granata G, Grignolo S, Grossi PA, Guadagnino G, Lagi F, Maraolo AE, Marinò V, Mazzitelli M, Mularoni A, Oliva A, Pace MC, Parisini A, Patti F, Petrosillo N, Pota V, Raffaelli F, Rossi M, Santoro A, Tascini C, Torti C, Trecarichi EM, Venditti M, Viale P, Signori A, Bassetti M, Del Bono V, Giannella M, Mikulska M, Tumbarello M, Viscoli C; SITA GIOVANI (Young Investigators Group of the Società Italiana Terapia Antinfettiva) and the COLI-CROSS Study Group. Giacobbe DR, et al. Among authors: bolla c. J Glob Antimicrob Resist. 2020 Mar;20:43-49. doi: 10.1016/j.jgar.2019.06.009. Epub 2019 Jun 15. J Glob Antimicrob Resist. 2020. PMID: 31207379 Free article.
Factors Associated With Weight Gain in People Treated With Dolutegravir.
Taramasso L, Bonfanti P, Ricci E, Orofino G, Squillace N, Menzaghi B, De Socio GV, Madeddu G, Pellicanò GF, Pagnucco L, Celesia BM, Calza L, Conti F, Martinelli CV, Valsecchi L, Cascio A, Bolla C, Maggi P, Vichi F, Dentone C, Angioni G, Mastroianni A, Falasca K, Cenderello G, Di Biagio A. Taramasso L, et al. Among authors: bolla c. Open Forum Infect Dis. 2020 May 26;7(6):ofaa195. doi: 10.1093/ofid/ofaa195. eCollection 2020 Jun. Open Forum Infect Dis. 2020. PMID: 32577427 Free PMC article.
A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold.
Lupia T, Montrucchio G, Gaviraghi A, Musso G, Puppo M, Bolla C, Shbaklo N, Rizzello B, Della Selva A, Concialdi E, Rumbolo F, Barbui AM, Brazzi L, De Rosa FG, Corcione S. Lupia T, et al. Among authors: bolla c. J Fungi (Basel). 2022 Nov 30;8(12):1264. doi: 10.3390/jof8121264. J Fungi (Basel). 2022. PMID: 36547597 Free PMC article.
Adherence to 2015 ESC Guidelines for the Treatment of Infective Endocarditis: A Retrospective Multicentre Study (LEIOT Study).
Pallotto C, Bolla C, Penpa S, Genga G, Sarda C, Svizzeretto E, Tommasi A, Stolaj E, Salvaderi A, Piceni G, Maconi A, Chichino G, Francisci D, On Behalf Of The Leiot Study Group. Pallotto C, et al. Among authors: bolla c. Antibiotics (Basel). 2023 Apr 4;12(4):705. doi: 10.3390/antibiotics12040705. Antibiotics (Basel). 2023. PMID: 37107067 Free PMC article.
Impact of septic episodes caused by Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa in a tertiary hospital: clinical and economic considerations in years 2018-2020.
Garlasco J, Beqiraj I, Bolla C, Marino EMI, Zanelli C, Gualco C, Rocchetti A, Gianino MM. Garlasco J, et al. Among authors: bolla c. J Infect Public Health. 2023 Apr;16(4):475-482. doi: 10.1016/j.jiph.2023.02.007. Epub 2023 Feb 10. J Infect Public Health. 2023. PMID: 36801627 Free article.
Level of implementation of multimodal strategies for infection prevention and control interventions and prevalence of healthcare-associated infections in Northern Italy.
Vicentini C, Bussolino R, Gastaldo C, Castagnotto M, D'Ancona FP, Zotti CM; Working group “Unità Prevenzione Rischio Infettivo (UPRI), Regione Piemonte”. Vicentini C, et al. Antimicrob Resist Infect Control. 2024 Apr 11;13(1):39. doi: 10.1186/s13756-024-01398-1. Antimicrob Resist Infect Control. 2024. PMID: 38605378 Free PMC article.